secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENEREX PHARMA, INC. (RGPX)
CIK:        0001357878
Form:       8-K
Filed at:   2022-08-26T23:59:59+00:00
Accession:  0001472375-22-000082
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Regenerex Pharma announces CFO, director resignations; appoints Lee Ori to board, Deborah Pilant as CFO
--------------------------------------------------------------------------------

- Irene Getty resigned as CFO, Bruce Sellars resigned from board, Byron Striloff resigned as officer, all effective Aug 25, 2022.
- Dr. Lee Ori appointed to board effective Aug 25; he also serves as COO. Background: pharmacy doctorate, Eli Lilly, multiple pharmacist licenses.
- Deborah L. Pilant appointed CFO effective Aug 25; already serving as Secretary/Treasurer and Director. Background in education, construction, sales.
- No reason given for departures or any financial impact disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/ixform8k.htm
  HTML page:      https://secwatch.observer/filing/0001472375-22-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer